Formed of the 3rd Annual Biomarkers Europe and 2nd Annual Precision Oncology Europe Congresses, Biomarkers Europe 2024 is focused on driving the advancement of biomarkers within the fields of oncology and immunotherapy.

The co-located events provide a specialized platform to explore the most innovative technologies and approaches for biomarker validation & Identification, biomarker analysis, applications in precision oncology & patient treatment in clinical trials.

With over 50 presentations, these two-day congresses provide multiple opportunities for engaging scientific insights, valuable networking, and interactive panel & workshop discussions.

Over 500 leading industry experts and clinicians will engage on biomarker end points, personalised patient treatment and companion diagnostics development including early detection technologies & liquid biopsies.

Event Link here.